CTLA4 and neoplasm: Though no significant difference in tumor infiltrated lymphocytes between different groups was observed, the CTLA-4 blocking antibody encapsulated PEGylated liposomes group showed the highest CD8+ T cells, T effector to Treg ratio, the best tumor inhibition, and the highest survival rate in CT26 colon carcinoma tumor models.